Jci_page_head_homepage_01 Jci_page_head_homepage_02
PACAP type I receptor activation regulates ECL cells and gastric acid secretion
Ningxin Zeng, Christoph Athmann, Tao Kang, Rong-Ming Lyu, John H. Walsh, Gordon V. Ohning, George Sachs, Joseph R. Pisegna
Published in Volume 104, Issue 10
J Clin Invest. 1999; 104(10):1383–1391 doi:10.1172/JCI7537
This article Copyright © 1999, The American Society for Clinical Investigation
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

RT-PCR of ECL-cell and parietal-cell RNA. (a) RT-PCR performed on ECL cell RNA using primers specific to the third intracellular loop splice variants. Sense primers (S1, HipS, HOPS, SV3AS) were used together with antisense primers (S1, HipS, HOPS, SV3AS) that spanned the intron-exon junctions as described previously (23). Amplification using primers for β-actin was performed as a control and is shown in the last lane. (b) RT-PCR performed on purified ECL and parietal cells (PC). The primers used were designed to amplify PAC1, histidine decarboxylase (HDC), H,K-ATPase, and β-actin in these 2 purified cell preparations (>85%).

Copyright © 2011 American Society for Clinical Investigation.
The JCI is the publication of the ASCI, an honor society of physician-scientists.
Copying, redistribution, and other usage policies